Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

229
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
229
Long-term Depression01:05

Long-term Depression

31.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.5K
Depression: Overview01:18

Depression: Overview

395
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
395
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

231
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
231
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

392
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
392
Cognitive Therapy01:25

Cognitive Therapy

477
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderators and predictors of treatment outcome for OCD: A comparison of cognitive behavioral therapy Exposure Response Prevention to Acceptance and Commitment Therapy.

Psychotherapy research : journal of the Society for Psychotherapy Research·2026
Same author

[Artificial light at night].

Ugeskrift for laeger·2026
Same author

Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS).

Trials·2026
Same author

Algorithm-guided treatment for major depressive disorder versus treatment as usual: a systematic review.

Frontiers in psychiatry·2026
Same author

Active versus sham transcranial pulsed electromagnetic field headband treatment for major depression: protocol for a double-blinded randomised trial.

BMJ open·2025
Same author

Collaborative challenges during transition of patients with severe depression from secondary mental health services to primary care and opportunities for improvement - a qualitative study.

Frontiers in psychiatry·2025
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.9K

[Light therapy for depression].

Helle Østergaard Madsen1, Sune Pv Straszek2, Mette Kragh3

  • 1Københavns Universitetshospital - Psykiatrisk Center København.

Ugeskrift for Laeger
|April 12, 2022
PubMed
Summary
This summary is machine-generated.

Artificial light therapy is a proven depression treatment, now used for various forms beyond seasonal depression. This review explores using natural or simulated daylight to enhance hospital treatments for mood disorders.

More Related Videos

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

632
A Protocol for Transcranial Photobiomodulation Therapy in Mice
13:07

A Protocol for Transcranial Photobiomodulation Therapy in Mice

Published on: November 18, 2018

12.3K

Related Experiment Videos

Last Updated: Sep 27, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.9K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

632
A Protocol for Transcranial Photobiomodulation Therapy in Mice
13:07

A Protocol for Transcranial Photobiomodulation Therapy in Mice

Published on: November 18, 2018

12.3K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Chronobiology

Background:

  • Artificial light therapy has treated depression since the 1980s.
  • Indications expanded from seasonal to non-seasonal depression (bipolar, geriatric, chronic).
  • Light impacts circadian and emotional regulation via retinohypothalamic pathways.

Purpose of the Study:

  • To review strategies for using natural or simulated daylight in hospitals.
  • To improve light-based depression treatment efficacy.
  • To optimize lighting for patient well-being and mood regulation.

Main Methods:

  • Literature review of light therapy research.
  • Analysis of retinohypothalamic mechanisms in mood disorders.
  • Examination of hospital lighting strategies and technologies.

Main Results:

  • Light therapy's effectiveness is supported by retinohypothalamic pathways.
  • Dynamic spectrum and intensity mimicry are key for simulated daylight.
  • Hospital settings can integrate advanced lighting for therapeutic benefits.

Conclusions:

  • Optimizing light exposure is crucial for treating diverse depressive disorders.
  • Simulating natural daylight offers a promising therapeutic avenue.
  • Future hospital designs should prioritize light's role in mental health treatment.